ARCHIVES

B-14 Trial: No Advantage To 10 Years Of Tamoxifen

This article is from The Cancer Letter archive.

Vol. 24 No. 5 | May 25, 2001

Download PDF Visit The Full Archive

Related Articles

Fisher Files Motion In Database Flagging Suit; Documents Examine Role Of Former NCI Director Broder

October 20, 1995

Gene Variant Associated With 44 Percent Cancer Risk Reduction

October 26, 2012

Oncology Nursing Foundation Offers Research Fellowship, Clinical Scholar Award

September 29, 1995

Science Fellowships Available; Grants For Former Soviet Scientists

August 16, 1996

Dear ASCO Member Letter From Klausner Attempts To Rescue Flagging BMT Trial.

June 2, 2000

In Brief: Hatch Bill Would Require NDA Sponsors To Pay Fee; IND, Generic Drug NDAs Would Be Exempt

August 22, 1986